MicroRNA expression signature of human sarcomas
- PMID: 17922033
- DOI: 10.1038/sj.onc.1210836
MicroRNA expression signature of human sarcomas
Abstract
MicroRNAs (miRNAs) are approximately 22 nucleotide-long noncoding RNAs involved in several biological processes including development, differentiation and proliferation. Recent studies suggest that knowledge of miRNA expression patterns in cancer may have substantial value for diagnostic and prognostic determinations as well as for eventual therapeutic intervention. We performed comprehensive analysis of miRNA expression profiles of 27 sarcomas, 5 normal smooth muscle and 2 normal skeletal muscle tissues using microarray technology and/or small RNA cloning approaches. The miRNA expression profiles are distinct among the tumor types as demonstrated by an unsupervised hierarchical clustering, and unique miRNA expression signatures were identified in each tumor class. Remarkably, the miRNA expression patterns suggested that two of the sarcomas had been misdiagnosed and this was confirmed by reevaluation of the tumors using histopathologic and molecular analyses. Using the cloning approach, we also identified 31 novel miRNAs or other small RNA effectors in the sarcomas and normal skeletal muscle tissues examined. Our data show that different histological types of sarcoma have distinct miRNA expression patterns, reflecting the apparent lineage and differentiation status of the tumors. The identification of unique miRNA signatures in each tumor type may indicate their role in tumorigenesis and may aid in diagnosis of soft tissue sarcomas.
Similar articles
-
Differential expression of microRNAs in mouse embryonic bladder.Biochem Biophys Res Commun. 2009 Aug 7;385(4):528-33. doi: 10.1016/j.bbrc.2009.05.088. Epub 2009 May 24. Biochem Biophys Res Commun. 2009. PMID: 19470377
-
Identification of altered MicroRNA expression patterns in synovial sarcoma.Genes Chromosomes Cancer. 2011 Mar;50(3):137-45. doi: 10.1002/gcc.20837. Epub 2010 Dec 7. Genes Chromosomes Cancer. 2011. PMID: 21213367
-
Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709. Genes Chromosomes Cancer. 2009. PMID: 19760605
-
MicroRNA expression profiling in cancer from a bioinformatics prospective.Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787. Expert Rev Mol Diagn. 2007. PMID: 18020908 Review.
-
Strategies for profiling microRNA expression.J Cell Physiol. 2009 Jan;218(1):22-5. doi: 10.1002/jcp.21577. J Cell Physiol. 2009. PMID: 18767038 Review.
Cited by
-
Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions.Mol Cancer Res. 2023 Jun 1;21(6):511-524. doi: 10.1158/1541-7786.MCR-22-1008. Mol Cancer Res. 2023. PMID: 37052491 Free PMC article. Review.
-
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs.Int J Mol Sci. 2022 Oct 14;23(20):12248. doi: 10.3390/ijms232012248. Int J Mol Sci. 2022. PMID: 36293105 Free PMC article.
-
Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors.Front Oncol. 2022 Sep 6;12:933248. doi: 10.3389/fonc.2022.933248. eCollection 2022. Front Oncol. 2022. PMID: 36147927 Free PMC article. Review.
-
Association between microRNA 671 polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population.Front Oncol. 2022 Aug 9;12:960269. doi: 10.3389/fonc.2022.960269. eCollection 2022. Front Oncol. 2022. PMID: 36016604 Free PMC article.
-
Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance.Cancer Drug Resist. 2021 Oct 26;4(4):934-945. doi: 10.20517/cdr.2021.62. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582382 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
